Sodium thiosulfate ameliorates oxidative stress and preserves renal function in hyperoxaluric rats

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Bijarnia, Rakesh K ^a   Bachtler, Matthias ^a   Chandak, Prakash G ^a   Van Goor, Harry ^b   Pasch, Andreas ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DRINKING WATER; ETHYLENE GLYCOL; HYDROGEN PEROXIDE; OXALIC ACID; PROSTAGLANDIN; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE; SODIUM THIOSULFATE; SUPEROXIDE DISMUTASE; ANTIOXIDANT; THIOSULFATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BIOACCUMULATION; CALCIUM OXALATE CRYSTALLURIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYSTALLIZATION; CRYSTALLURIA; DRUG EFFECT; ENZYME ACTIVITY; HYPEROXALURIA; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FUNCTION; KIDNEY INJURY; LLC PK1 CELL LINE; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; RENAL PROTECTION; TREATMENT RESPONSE; ANIMAL; DISEASE MODEL; DRUG EFFECTS; KIDNEY; KIDNEY FUNCTION TEST; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY;

ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; HYPEROXALURIA; KIDNEY; KIDNEY FUNCTION TESTS; MALE; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; THIOSULFATES;

EID: 84953251851     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124881     Document Type: Article

References (43)

1. Lorenzo V, Torres A, Salido E. Primary hyperoxaluria. Nephrologia. 2014;34:398-412.
2. Thamilselvan V, Menon M, Thamilselvan S. Oxalate at physiological urine concentrations induces oxidative injury in renal epithelial cells: Effect of α-tocopherol and ascorbic acid. BJU Int. 2014;114:140-150. doi: 10.1111/bju.12642 PMID: 24460843
3. Lee HJ, Jeong SJ, Lee HJ, Lee EO, Bae H, Lieske JC, et al. 1, 2, 3, 4, 6-Penta-O-galloyl-beta-D-glucose reduces renal crystallization and oxidative stress in a hyperoxaluric rat model. Kidney Int. 2011;79:538-545. doi: 10.1038/ki.2010.458 PMID: 21085110
4. Hirose M, Yasui T, Okada A, Hamamoto S, Shimizu H, Itoh Y, et al. Renal tubular epithelial cell injury and oxidative stress induce calcium oxalate crystal formation in mouse kidney. Int J Urol. 2010;17:83-92. doi: 10.1111/j.1442-2042.2009.02410.x PMID: 19919640
5. Park HK, Jeong BC, Sung MK, Park MY, Choi EY, Kim BS, et al. Reduction of oxidative stress in cultured renal tubular cells and preventive effects on renal stone formation by the bioflavonoid quercetin. J Urol. 2008;179:1620-1626. doi: 10.1016/j.juro.2007.11.039 PMID: 18295251
6. Smith VM, Oliphant T, Shareef M, Merchant W, Wilkinson SM. Calciphylaxis with normal renal function: treated with intravenous sodium thiosulfate. Clin Exp Dermatol. 2012;37:874-878. doi: 10.1111/j. 1365-2230.2012.04350.x PMID: 22548382
7. Yatzidis H. Successful sodium thiosulphate treatment for recurrent calcium urolithiasis. Clin Nephrol. 1985;23:63-67. PMID: 3886226
8. Meissner M, Bauer R, Beier C, Betz C, Wolter M, Kaufmann R, et al. Sodium thiosulphate as a promising therapeutic option to treat calciphylaxis. Dermatology. 2006;212:373-376. PMID: 16707889
9. Pasch A, Schaffner T, Huynh-Do U, Frey BM, Frey FJ, Farese S. Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int. 2008;74:1444-1453. doi: 10.1038/ki.2008.455 PMID: 18818688
10. Asplin JR, Donahue SE, Lindeman C, Michalenka A, Strutz KL, Bushinsky DA. Thiosulfate reduces calcium phosphate nephrolithiasis. J Am Soc Nephrol. 2009;20:1246-1253. doi: 10.1681/ASN. 2008070754 PMID: 19369406
11. Hayden MR, Tyagi SC, Kolb L, Sowers JR, Khanna R. Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate. Cardiovasc Diabetol. 2005;4:4. PMID: 15777477
12. La Grange CA, Lele SM, Pais VM Jr. The effect of sodium thiosulfate administration on nephrocalcinosis in a rat model. J Endourol. 2009;23:529-533. doi: 10.1089/end.2008.0204 PMID: 19193134
13. Thamilselvan S, Menon M. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status. BJU Int. 2005;96:117-126. PMID: 15963133
14. Mulder GM, Nijboer WN, Seelen MA, Sandovici M, Bos EM, Melenhorst WB, et al. Heparin binding epidermal growth factor in renal ischaemia/reperfusion injury. J Pathol. 2010;221:183-192. doi: 10.1002/path.2698 PMID: 20225242
15. Failli P, Palmieri L, D'Alfonso C, Giovannelli L, Generini S, Rosso AD, et al. Effect of N acetyl-l-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis. Nitric oxide. 2002;7:277-282. PMID: 12446176
16. Farese S, Stauffer E, Kalicki R, Hildebrandt T, Frey BM, Frey FJ, et al. Sodium thiosulfate pharmacokinetics in hemodialysis patients and healthy volunteers. Clin J Am Soc Nephrol. 2011;6:1447-1455. doi: 10.2215/CJN.10241110 PMID: 21566113
17. Schepers MS, van Ballegooijen ES, Bangma CH. Crystals cause acute necrotic cell death in renal proximal tubule cells, but not in collecting tubule cells. Kidney Int. 2005;68(4):1543-1553. PMID: 16164631
18. Bodakhe KS, Namdeo KP, Patra KC, Machwal L, Pareta SK, et al. A polyherbal formulation attenuates hyperoxaluria-induced oxidative stress and prevents subsequent deposition of calcium oxalate crystals and renal cell injury in rat kidneys. Chin J Nat Med. 2013;11:466-471. doi: 10.1016/S1875-5364 (13) 60085-0 PMID: 24359768
19. Samarneh MM, Shtaynberg N, Goldman M, Epstein E, Kleiner M, El-Sayegh S. Severe oxalosis with systemic manifestations. J Clin Med Res. 2012;4:56-60. doi: 10.4021/jocmr525w PMID: 22383929
20. Khan SR. Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations. J Urol. 2013;189:803-811. doi: 10. 1016/j.juro.2012.05.078 PMID: 23022011
21. Mulay SR, Kulkarni OP, Rupanagudi KV, Migliorini A, Darisipudi MN, Vilaysane A, et al. Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion. J Clin Invest. 2013;123:236-246. doi: 10.1172/JCI63679 PMID: 23221343
22. Tanriverdi O, Telci D, Aydin M, Ekici ID, Miroglu C, Sarica K. Hyperoxaluria-induced tubular ischemia: the effects of verapamil and vitamin E on apoptotic changes with an emphasis on renal papilla in rat model. Urol Res. 2012;40:17-25. doi: 10.1007/s00240-011-0388-4 PMID: 21607878
23. Yonova D, Vazelov E, Trendafilov II, Stoinova VV, Nedevska MT, Antonov SA. First impressions of cardiovascular calcification treatment in hemodialysis patients with a new dialysis fluid containing sodium thiosulphate (STS). Int J Artif Organs. 2014;37:308-314. doi: 10.5301/ijao.5000309 PMID: 24811185
24. Malbos S, Urena-Torres P, Cohen-Solal M, Trout H, Lioté F, Bardin T, et al. Sodium thiosulphate treatment of uraemic tumoral calcinosis. Rheumatology. 2014;53:547-551. doi: 10.1093/rheumatology/ket388 PMID: 24292346
25. Mathews SJ, de las Fuentes L, Podaralla P, Cabellon A, Zheng S, Bierhals A, et al. Effects of sodium thiosulfate on vascular calcification in end-stage renal disease: a pilot study of feasibility, safety and efficacy. Am J Nephrol. 2011;33:131-138. doi: 10.1159/000323550 PMID: 21242673
26. Holt C, Lenton S, Nylander T, Sørensen ES, Teixeira SC. Mineralisation of soft and hard tissues and the stability of biofluids. J Struct Biol. 2014;185:383-396. doi: 10.1016/j.jsb.2013.11.009 PMID: 24316224
27. Bashir S, Gilani AH. Antiurolithic effect of berberine is mediated through multiple pathways. Eur J Pharmacol. 2011;651:168-175. doi: 10.1016/j.ejphar.2010.10.076 PMID: 21114977
28. Ullrich K, Rumrich G, Klöss S. Bidirectional active transport of thiosulfate in the proximal convolution of the rat kidney. Pflugers Arch. 1980;387:127-132. PMID: 7191976
29. Gáspár S, Niculişe C, Cucu D, Marcu I. Effect of calcium oxalate on renal cells as revealed by real-time measurement of extracellular oxidative burst. Biosens Bioelectron. 2010;25:1729-1734. doi: 10.1016/j.bios.2009.12.013 PMID: 20047824
30. Thamilselvan V, Menon M, Thamilselvan S. Oxalate-induced activation of PKC-α and-δ regulates NADPH oxidase-mediated oxidative injury in renal tubular epithelial cells. Am J Physiol Renal Physiol. 2009;297:F1399-F1410. doi: 10.1152/ajprenal.00051.2009 PMID: 19692488
31. Zuo J, Khan A, Glenton PA, Khan SR. Effect of NADPH oxidase inhibition on the expression of kidney injury molecule and calcium oxalate crystal deposition in hydroxy-L-proline-induced hyperoxaluria in the male Sprague-Dawley rats. Nephrol Dial Transplant. 2011;26:1785-1796. doi: 10.1093/ndt/gfr035 PMID: 21378157
32. Selvam R. Calcium oxalate stone disease: role of lipid peroxidation and antioxidants. Urol Res. 2002;30:35-47. PMID: 11942324
33. Selvam R, Vijaya A. Effect of renal ischaemia reperfusion on calcium oxalate retention. Indian J Med Res. 2000;111:62-68. PMID: 10824469
34. Meimaridou E, Jacobson J, Seddon AM, Noronha-Dutra AA, Robertson WG, Hothersall JS. Crystal and microparticle effects on MDCK cell superoxide production: oxalate-specific mitochondrial membrane potential changes. Free Radic Biol Med. 2005;38:1553-1564. PMID: 15917184
35. 2-), Superoxide Dismutases, and Related Matters. J Biol Chem. 1997;272:18515-18517. PMID: 9228011
36. Tuan LQ, Umakoshi H, Shimanouchi T, Kuboi R. Liposome membrane can act like molecular and metal chaperones for oxidized and fragmented superoxide dismutase. Enzyme Mocrob Technol. 2009;44:101-106.
37. 3]. Acta Phys Chim Sin. 2004;20:772-775.
38. Bijarnia RK, Kaur T, Aggarwal K, Singla SK, Tandon C. Modulatory effects of N-acetylcysteine on hyperoxaluric manifestations in rat kidney. Food Chem Toxicol. 2008;46:2274-2278. doi: 10.1016/j. fct.2008.03.007 PMID: 18423961
39. Huang HS, Ma MC, Chen J. Low-vitamin E diet exacerbates calcium oxalate crystal formation via enhanced oxidative stress in rat hyperoxaluric kidney. Am J Physiol Renal Physiol. 2009;296:F34-F45. doi: 10.1152/ajprenal.90309.2008 PMID: 18799548
40. Nath KA, Norby SM. Reactive oxygen species and acute renal failure. Am J Med. 2010;109:665-678.
41. Li CY, Deng YL, Sun BH. Taurine protected kidney from oxidative injury through mitochondrial-linked pathway in a rat model of nephrolithiasis. Urol Res. 2009;37:211-220. doi: 10.1007/s00240-009-0197-1 PMID: 19513707
42. Byon CH, Javed A, Dai Q, Kappes JC, Clemens TL, Darley-Usmar VM, et al. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem. 2008;283:15319-15327. doi: 10.1074/jbc. M800021200 PMID: 18378684
43. van den Berg E, Pasch A, Westendorp WH, Navis G, Brink EJ, Gans RO, et al. Urinary Sulfur Metabolites are Associated with a Favorable Cardiovascular Risk Profile and Survival Benefit in Renal Transplant Recipients. J Am Soc Nephrol. 2014;25:1303-1312. doi: 10.1681/ASN.2013050497 PMID: 24511127